SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $204,972 | -47.3% | 9,984 | -38.9% | 0.03% | -40.8% |
| Q1 2024 | $388,844 | +123.3% | 16,338 | +102.8% | 0.05% | +44.1% |
| Q4 2023 | $174,133 | +573.0% | 8,058 | +352.2% | 0.03% | +325.0% |
| Q3 2023 | $25,875 | +37.1% | 1,782 | +97.6% | 0.01% | +33.3% |
| Q2 2023 | $18,879 | -3.7% | 902 | -2.8% | 0.01% | -14.3% |
| Q1 2023 | $19,599 | +25.8% | 928 | +51.6% | 0.01% | +16.7% |
| Q4 2022 | $15,575 | +19.8% | 612 | +15.5% | 0.01% | +20.0% |
| Q3 2022 | $13,000 | – | 530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |